Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Colin Geary Visiting Professor

Professor Roger Reddel: How can every cancer patient benefit from "big data"?

Director of Children’s Medical Research Institute and the Sir Lorimer Dods Professor, Sydney Medical School, University of Sydney

Roger Reddell_picIt has been long understood that individual cancers may require specifically tailored treatments. Although good progress has been made over many decades, there is still a long way to go. In recent years, there have been extraordinary advances in our ability to obtain enormous quantities of data about the molecules inside cancers, and to make sense of this data through computer analyses. This has greatly enhanced our understanding of cancer.

In this free public lecture, Professor Reddel will discuss how we can harness the power of big data to enhance the accuracy of treatment decisions for every individual cancer patient.

Thursday 20 July 6pm
Dunedin Public Art gallery
Complimentary refreshments from 5:30pm

Free of charge. All welcome

DOWNLOAD THE POSTER (PDF 1.52MB)

Professor Roger Reddel BSc (Med), MBBS PhD FRACP FAA is the Director of Children’s Medical Research Institute (CMRI) and the Sir Lorimer Dods Professor, Sydney Medical School, University of Sydney. He also heads CMRI’s Cancer Research Unit and directs CellBank Australia.

Professor Reddel’s research is focussed on the molecular genetics of immortalisation, the process that allows cancer cells to divide an unlimited number of times. He and his group are best known for their work on telomerase, the enzyme on which 85% of cancers depend for their unlimited growth, and for discovering Alternative Lengthening of Telomeres (ALT) upon which the remaining – 10% depend. The goal of this work is to understand the immortalisation process in sufficient detail to make it possible to design treatments that specifically limit cancer cell proliferation. The aim of this research is to develop new forms of cancer treatment that prevent cell growth by blocking immortalisation. Professor Reddel was awarded the Ramaciotti Medal for Excellence in Biomedical Research in 2007, was elected as a Fellow of the Australian Academy of Science in 2010, and in 2011 received the NSW Premier’s Award for Outstanding Cancer Researcher of the Year.

He is a director of Cure Cancer Australia Foundation and serves on editorial boards of a number of international cancer research journals, and on national and international scientific advisory panels.

For any enquiries about this lecture, please contact Alison Tait on alison.tait@otago.ac.nz or 03 479 7142